What does Stop the Importation and Manufacturing of Synthetic Analogues Act of 2025 do?

This bill establishes a new Schedule A for controlled substances under the Controlled Substances Act and creates a framework for regulating these substances. It grants the Attorney General authority to temporarily schedule emerging drugs of concern, imposes strict penalties for Schedule A violations, and sets requirements for research, manufacturing, import, and export of Schedule A substances. The legislation aims to provide law enforcement with tools to respond rapidly to new synthetic drugs while maintaining avenues for legitimate research and development.

Chuck Grassley, Margaret Hassan, Joni Ernst, Jeanne Shaheen, Shelley Capito

What is the status of S3228?

Introduced as of November 20, 2025.

S3228 U.S. Senate: Stop the Importation and Manufacturing…

Introduced

S. 3228

Introduced in Senate · November 26, 2025

November 20, 2025

Mr. Grassley (for himself, Ms. Hassan, Ms. Ernst, Mrs. Shaheen, and Mrs. Capito) introduced the following bill; which was read twice and referred to the Committee on the Judiciary

A BILL

To amend the Controlled Substances Act to clarify how controlled substance analogues that are imported or offered for import are to be regulated, and for other purposes.

1. Short title; table of contents; 2. Establishment of Schedule A; 3. Temporary and permanent scheduling of schedule A substances; 4. Penalties; 5. False labeling of schedule A controlled substances; 6. Registration requirements for schedule A substances; 7. Additional conforming amendments; 8. Sentencing review; 9. Rules of construction

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

S.3228

S. 3228

S.3228

S. 3228